Clinical/genetic features in hereditary breast cancer

Henry T. Lynch, P. Watson, T. A. Conway, J. F. Lynch

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Patients from hereditary breast cancer-prone (HBC) families provide one of the most powerful and potentially cost effective models for cancer prevention and control. Paradoxically, this opportunity is often missed in the clinical practice setting due, to inattention to the family history and/or lack of knowledge about breast cancer genetics. We describe the family study process, wherein documentation of genealogy, medical, and cancer history through pathology verification is attained, often on extended families. The findings of such studies are illustrated by description of nine breast cancer-prone families. These families illustrate several important clinical/genetic features such as age of cancer onset, bilaterality and/or multiple primary cancer occurrences, incomplete gene penetrance, and the identification of putative obligate gene carriers. Interpretation of HBC pedigrees is dependent upon the understanding of these issues, which in turn may enable the physician to more readily identify those individuals who might benefit from highly targeted breast cancer control measures.

Original languageEnglish
Pages (from-to)63-71
Number of pages9
JournalBreast Cancer Research and Treatment
Volume15
Issue number2
DOIs
StatePublished - 1990

Fingerprint

Breast Neoplasms
Neoplasms
Genealogy and Heraldry
Penetrance
Pedigree
Age of Onset
Documentation
Genes
Pathology
Physicians
Costs and Cost Analysis

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Clinical/genetic features in hereditary breast cancer. / Lynch, Henry T.; Watson, P.; Conway, T. A.; Lynch, J. F.

In: Breast Cancer Research and Treatment, Vol. 15, No. 2, 1990, p. 63-71.

Research output: Contribution to journalArticle

Lynch, Henry T. ; Watson, P. ; Conway, T. A. ; Lynch, J. F. / Clinical/genetic features in hereditary breast cancer. In: Breast Cancer Research and Treatment. 1990 ; Vol. 15, No. 2. pp. 63-71.
@article{119d825498c04d77873f65d56b7dc0fc,
title = "Clinical/genetic features in hereditary breast cancer",
abstract = "Patients from hereditary breast cancer-prone (HBC) families provide one of the most powerful and potentially cost effective models for cancer prevention and control. Paradoxically, this opportunity is often missed in the clinical practice setting due, to inattention to the family history and/or lack of knowledge about breast cancer genetics. We describe the family study process, wherein documentation of genealogy, medical, and cancer history through pathology verification is attained, often on extended families. The findings of such studies are illustrated by description of nine breast cancer-prone families. These families illustrate several important clinical/genetic features such as age of cancer onset, bilaterality and/or multiple primary cancer occurrences, incomplete gene penetrance, and the identification of putative obligate gene carriers. Interpretation of HBC pedigrees is dependent upon the understanding of these issues, which in turn may enable the physician to more readily identify those individuals who might benefit from highly targeted breast cancer control measures.",
author = "Lynch, {Henry T.} and P. Watson and Conway, {T. A.} and Lynch, {J. F.}",
year = "1990",
doi = "10.1007/BF01810778",
language = "English",
volume = "15",
pages = "63--71",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Clinical/genetic features in hereditary breast cancer

AU - Lynch, Henry T.

AU - Watson, P.

AU - Conway, T. A.

AU - Lynch, J. F.

PY - 1990

Y1 - 1990

N2 - Patients from hereditary breast cancer-prone (HBC) families provide one of the most powerful and potentially cost effective models for cancer prevention and control. Paradoxically, this opportunity is often missed in the clinical practice setting due, to inattention to the family history and/or lack of knowledge about breast cancer genetics. We describe the family study process, wherein documentation of genealogy, medical, and cancer history through pathology verification is attained, often on extended families. The findings of such studies are illustrated by description of nine breast cancer-prone families. These families illustrate several important clinical/genetic features such as age of cancer onset, bilaterality and/or multiple primary cancer occurrences, incomplete gene penetrance, and the identification of putative obligate gene carriers. Interpretation of HBC pedigrees is dependent upon the understanding of these issues, which in turn may enable the physician to more readily identify those individuals who might benefit from highly targeted breast cancer control measures.

AB - Patients from hereditary breast cancer-prone (HBC) families provide one of the most powerful and potentially cost effective models for cancer prevention and control. Paradoxically, this opportunity is often missed in the clinical practice setting due, to inattention to the family history and/or lack of knowledge about breast cancer genetics. We describe the family study process, wherein documentation of genealogy, medical, and cancer history through pathology verification is attained, often on extended families. The findings of such studies are illustrated by description of nine breast cancer-prone families. These families illustrate several important clinical/genetic features such as age of cancer onset, bilaterality and/or multiple primary cancer occurrences, incomplete gene penetrance, and the identification of putative obligate gene carriers. Interpretation of HBC pedigrees is dependent upon the understanding of these issues, which in turn may enable the physician to more readily identify those individuals who might benefit from highly targeted breast cancer control measures.

UR - http://www.scopus.com/inward/record.url?scp=0025239903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025239903&partnerID=8YFLogxK

U2 - 10.1007/BF01810778

DO - 10.1007/BF01810778

M3 - Article

C2 - 2322650

AN - SCOPUS:0025239903

VL - 15

SP - 63

EP - 71

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -